http://www.mmm-online.com/weightloss/topic/20240/ Articles tagged with Weight-Loss from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no Analysts write expanded Qsymia distribution will do little to boost sales if payers are not on board. http://www.mmm-online.com/analysts-on-qsymia-show-me-the-payers/article/289207/ Wed, 17 Apr 2013 16:02:11 GMT Analysts write expanded Qsymia distribution will do little to boost sales if payers are not on board. MMM When it comes to OTC weight-loss products, deceptive advertising produces diminishing returns, a study has found. http://www.mmm-online.com/hyperbolic-otc-obesity-drug-ads-backfire/article/285193/ Wed, 20 Mar 2013 16:22:49 GMT When it comes to OTC weight-loss products, deceptive advertising produces diminishing returns, a study has found. MMM The drug maker is promoting the no-fee, all-access app to healthcare professionals as part of its Qsymia pitch. http://www.mmm-online.com/vivus-launches-qsymia-weight-loss-app/article/284171/ Wed, 13 Mar 2013 14:59:48 GMT The drug maker is promoting the no-fee, all-access app to healthcare professionals as part of its Qsymia pitch. MMM Orexigen slashed its clinical trial recruitment period by 14 months using marketing tactics associated with retail. http://www.mmm-online.com/orexigen-rethinks-clinical-trial-recruitment/article/277478/ Thu, 24 Jan 2013 18:58:38 GMT Orexigen slashed its clinical trial recruitment period by 14 months using marketing tactics associated with retail. MMM The category that saw its first FDA-approved drug in 13 years is still waiting to take off. http://www.mmm-online.com/weight-loss-category-enters-2013-light-on-results/article/271319/ Wed, 05 Dec 2012 20:04:45 GMT The category that saw its first FDA-approved drug in 13 years is still waiting to take off. MMM PR firm Burson-Marsteller launched a new healthcare subsidiary, Orexigen's net loss widened in Q2, and Corcept closed out its first full quarter with orphan treatment Korlym. http://www.mmm-online.com/company-news-burson-marsteller-corcept-and-orexigen/article/253654/ Tue, 07 Aug 2012 15:13:13 GMT PR firm Burson-Marsteller launched a new healthcare subsidiary, Orexigen's net loss widened in Q2, and Corcept closed out its first full quarter with orphan treatment Korlym. MMM